. Department of P e d i a t r i c s , university o f California, san Diego, La J o l l a , C A 92093 3-Methylglutaconic a c i d u r i a has been described i n 7 p a t i e n t s i n whom urinary excretion of 3-methylglutaconic (3-MGC) and 3-methylglutaric (3-MGR) a c i d s were elevated. I n two s i b l i n g s t h e only manifestation was speech r e t a r d a t i o n . Combined excret i o n of 3-MGC and 3-MGR was 520-940 mmol/mol c r e a t i n i n e (normal l e s s than 6). The o t h e r p a t i e n t s had a p i c t u r e of severe neurol o g i c degeneration and profound mental r e t a r d a t i o n . Combined excretion of 3-MGC and 3-MGR ranged from a low o f 40 t o 800 m o l / m O l c r e a t i n i n e . The a c t i v i t y o f 3-methylulutaconyl-CoA (3-MGCoA) hydratase i n f i b r o b l a s t l y s a t e s derived from t h e s i b l i n g s with speech r e t a r d a t i o n was l e s s than 3% of t h e c o n t r o l l e v e l . In c o n t r a s t t h e a c t i v i t y of t h i s enzyme was normal i n t h r e e p a t i e n t s with t h e o t h e r c l i n i c a l phenotype. W e have postulated t h a t t h e excretion of 3-MGC and 3-MGR i n t h e p a t i e n t s with neurol o g i c a l abnormality i s a secondary accumulation i n response t o another primary d e f e c t not only because of t h e normal a c t i v i t y of t h e enzyme but because they a l s o excrete l a r g e q u a n t i t i e s of c i t r i c a c i d cycle intermediates. W e conclude t h a t t h e mild c l i ni c a l presentation of t h e s i b l i n g s we have s t u d i e d i s t h e c l i n i c a l p i c t u r e of 3-MG-CoA hydratase deficiency. These observations i n d i c a t e t h a t n e i t h e r t h e presence of nor t h e l e v e l of excretion of 3-MGC and 3-MGR c o r r e l a t e s with 3-MG-CoA hydratase deficiency. (Sponsored by Mark Ballow). Eleven p a t i e n t s with Hunter Syndrome (MPS f1) have been followed a t t h e University of Connecticut, of which 10 have been placed on a monthly leukocyte transfusion protocol. P o s i t i v e e f f e c t s of t h e transfusions have included softening of t h e skin and h a i r with r e s o l u t i o n of nodular skin l e s i o n s and diarrhea. W e have a l s o noted marked s u b j e c t i v e improvement of j o i n t d i scomfort i n those individuals who a r e a b l e t o communicate. No s i g n i f i c a n t improvement of macroglossia, organomegaly, s k e l e t a l , cardiovascular o r pulmonary changes have been noted.
l o g i c degeneration and profound mental r e t a r d a t i o n . Combined excretion of 3-MGC and 3-MGR ranged from a low o f 40 t o 800 m o l / m O l c r e a t i n i n e . The a c t i v i t y o f 3-methylulutaconyl-CoA (3-MGCoA) hydratase i n f i b r o b l a s t l y s a t e s derived from t h e s i b l i n g s with speech r e t a r d a t i o n was l e s s than 3% of t h e c o n t r o l l e v e l . In c o n t r a s t t h e a c t i v i t y of t h i s enzyme was normal i n t h r e e p a t i e n t s with t h e o t h e r c l i n i c a l phenotype. W e have postulated t h a t t h e excretion of 3-MGC and 3-MGR i n t h e p a t i e n t s with neurol o g i c a l abnormality i s a secondary accumulation i n response t o another primary d e f e c t not only because of t h e normal a c t i v i t y of t h e enzyme but because they a l s o excrete l a r g e q u a n t i t i e s of c i t r i c a c i d cycle intermediates. W e conclude t h a t t h e mild c l i ni c a l presentation of t h e s i b l i n g s we have s t u d i e d i s t h e c l i n i c a l p i c t u r e of 3-MG-CoA hydratase deficiency. These observations i n d i c a t e t h a t n e i t h e r t h e presence of nor t h e l e v e l of excretion of 3-MGC and 3-MGR c o r r e l a t e s with 3-MG-CoA hydratase deficiency. (Sponsored by Mark Ballow). Eleven p a t i e n t s with Hunter Syndrome (MPS f1) have been followed a t t h e University of Connecticut, of which 10 have been placed on a monthly leukocyte transfusion protocol. P o s i t i v e e f f e c t s of t h e transfusions have included softening of t h e skin and h a i r with r e s o l u t i o n of nodular skin l e s i o n s and diarrhea. W e have a l s o noted marked s u b j e c t i v e improvement of j o i n t d i scomfort i n those individuals who a r e a b l e t o communicate. No s i g n i f i c a n t improvement of macroglossia, organomegaly, s k e l e t a l , cardiovascular o r pulmonary changes have been noted. Previously, i t was f e l t t h a t m o r t a l i t y i n Hunter syndrome was frequently secondary t o cardiovascular complications. Our recent experience with 11 p a t i e n t s has shown t h a t t h e major morbidity i s r e l a t e d t o r e s p i r a t o r y disease, e s p e c i a l l y with regard t o upper airway compromise. Because of t h e unusual t r a c h e a l c a r t i l a g e conformation which develops i n these individuals, tracheostomy has been necessary i n 5/11 p a t i e n t s includi n g 213 individuals with t h e mild form of Hunter syndrome. Tracheostomy is a complex procedure i n t h e s e p a t i e n t s r e q u i r i n g non-standard techniques and appliances. These findings suggest t h a t pulmonary abnormalities may be t h e primary cause of m o r t a l i t y i n Hunter Syndrome. We a r e a l s o considering t h a t t h i s change i n t h e locus of morbidity may be due t o t h e delay of cardiovascular decompensation secondary t o t h e leukocyte transfusions.
REPRODUCTNE OUTCOME I h ' COUPLES WITH PREVI- of Medical Genetics, University of B r i t i s h Columbia, Vancouver, B.C. Congenital contractures a r e commonly present a t b i r t h . A s i n g l e contracture occurs i n a t l e a s t 1 i n 200 b i r t h s . Multiple congenital contractures (Arthrogryposis) occur i n about 1 i n 4,000 b i r t h s .
A study of multiple congenital contractures was undertaken among 350 p a t i e n t s diagnosed a s having Arthrogryposis i n order t o d i s t i n g u i s h genetic heterogeneity. These p a t i e n t s were i d e n t i f i e d from orthopedic and p e d i a t r i c h o s p i t a l s a s unknown diagnostic e n t i t i e s . Three c l i n i c a l subdivisions were u t il i z e d : 1) individuals with primarily limb involvement, 2) individuals with limb involvement plus other anomalies, 3 ) individuals with limb involvement plus c e n t r a l nervous system abnormali t i e s . A d i f f e r e n t i a l diagnosis and empiric recurrence r i s k was established on the b a s i s of these 3 categories. Within each category, a large number of s p e c i f i c e n t i t i e s were recognized and determined t o be genetic versus non-genetic.
Of the t o t a l study group, 80 or 23% were found t o have s i n g l e gene b a s i s , 9 o r 3% a chromosomal b a s i s , and 5 or 1% a m u l t i f a c t o r i a l basis. Thus, 27% of the t o t a l study group had a genetic b a s i s . Twenty-two or 6% had a recognizable environmental etiology. One hundred and sixty-four or 47% were recognized diagnoses which had no recurrence r i s k or g e n e t i c b a s i s , and 70 or 20% could not be identif i e d as having a s p e c i f i c syndrome. The recurrence r i s k t o pat i e n t s within the unknown group was approximately 5%. The popul a t i o n incidence of Arthrogryposis during the 5-year period i n Washington s t a t e was 1 i n 4,000 b i r t h s . Subjects were s e l e c t e d f r a n normal (NF) and asthma (AF) f a m i l i e s e n r o l l e d i n a Natural History o f Asthma study. Subjects were included in the a n a l y s i s i f t h e y d i d not have asthma, a l l e r g i c d i s e a s e or a r e c e n t r e s p i r a t o r y i n f e c t i o n . The M studies were performed by standard procedures (JACI 64:569,1979) , and expressed as the area under the b e s t -f i t t i n g paratola o f the, dose respnse curve. me-hundred eighty-four s u b j e c t s f r a n AF and 128 f r a n NF were included. Dept o f Biochemistry, Boston. Achondrogenesis I 1 i s an i n h e r i t e d disorder o f endochondral bone growth characterized c l i n i c a l l y by severe ( l e t h a l ) dwarfism and p a t h o l o g i c a l l y b y the production o f reduced amounts o f c a r t i l a g e matrix.
EVIDENCE THAT BRONCHIAL R E K T M T Y MAY BE
To f u r t h e r d e f i n e i t s pathogenesis, we s t u d i e d growth p l a t e t i s s u e from 4 p a t i e n t s by a combination o f microscopic and biochemical methods.
Immunostaining o f u n d e c a l i f i c i e d Spurr embedded sections w i t h a b a t t e r y o f collagen antibodies revealed t h a t t h e major collagen o f t h e r e s t i n g c a r t i l a g e m a t r i x was type I r a t h e r than t h e expected t y p e I 1 ( c a r t i l a g e ) collagen which was much reduced i n amount. Analysis o f r e s t i n g c a r t i l a g e c o l l a ens by SDS-PAGE and s i z e exclusion HPLC mapping o f cyanogen %romide peptides confirmed t h a t collagen I was t h e major collagen and f a i l e d t o d e t e c t collagen 11.
The r e s u l t s suggest a t l e a s t two p o s s i b i l i t i e s . F i r s t , there may be a d e f e c t i n t h e s t r u c t u r a l gene f o r collagen I 1 which i n t e r f e r e s w i t h t h e synthesis and/or s e c r e t i o n o f t h e p r o t e i n i n an analagous f a s h i o n t o t h a t which occurs f o r collagen I i n t h e osteogenesis imperfecta syndromes. A l t e r n a t i v e l y , t h e s e c r e t i o n o f collagen I ma reflec: ~r e m a t u r i t v and/or abnormal r e a u l a t i o n o f t h e normay "switch i r o m collagen I 1 t o collagen " I synthesis t h a t occurs d u r i n g l a t e r stages of growth p l a t e chondrocyte d i f f e r e n t i a t i o n .
I n any event t h e observations i n d i c a t e t h a t growth p l a t e collagen qroduction i s d i s t u r b e d i n t h e disorder.
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